Bruce Power receives
Bruce Power receives regulatory approval for new lifesaving medical isotope production
24 sept. 2021 15h14 HE | Bruce Power
Tiverton, Ontario, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Bruce Power has received approval from the Canadian Nuclear Safety Commission (CNSC) to take the next step forward for new isotope production...
New Technology at Ma
New Technology at Mary Bird Perkins Set to Revolutionize Cancer Treatment in Baton Rouge and Across Gulf South
22 sept. 2021 11h00 HE | Mary Bird Perkins Cancer Center
BATON ROUGE, LA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- As Mary Bird Perkins Cancer Center celebrates its 50th anniversary, the organization is announcing a new, transformational development solidifying...
anpac_logo_full color_stacked.png
AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions
05 août 2021 07h30 HE | Anpac Bio, USA
PHILADELPHIA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
anpac_logo_full color_stacked.png
AnPac Bio Began Generating Contract Medical Device R&D Revenue
21 juil. 2021 06h30 HE | Anpac Bio, USA
PHILADELPHIA, July 21, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
LIXTE.jpg
Lixte Biotechnology to Present its Drug Development Pipeline for Cancer Treatment at The MoneyShow Virtual Expo on July 14, 2021
07 juil. 2021 09h35 HE | Lixte Biotechnology Holdings, Inc.
Presentation to highlight Company’s current clinical study of lead compound LB-100 for Small Cell Lung Cancer ALTADENA, CA, July 07, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc....
visiongain Logo.png
European Antibiotics Market Size Worth US$17,778.6 Million by 2031: Visiongain Research, Inc.
01 juil. 2021 12h00 HE | Visiongain Ltd
Visiongain has published a new report on “European Antibiotics Market 2021-2031”. Forecasts by Drug Class (Cephalosporin, Fluoroquinolone, Penicillin, Carbapenem, Macrolide, Sulfonamide, Amino...
visiongain Logo.png
Cancer Diagnostics Market worth US$1,16,276.2 Million in 2031: Visiongain Research Inc.
21 juin 2021 11h30 HE | Visiongain Ltd
Visiongain has published a new report on “Cancer Diagnostics Market Forecast of 2021 to 2031”. Forecasts by Test Type {(Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, BRCA Tests, CA-19...
anpac_logo_full color_stacked.png
AnPac Bio’s First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds
18 juin 2021 06h30 HE | Anpac Bio, USA
PHILADELPHIA, June 18, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
LIXTE.jpg
Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB-100 for Treatment of Small Cell Lung Cancer
02 juin 2021 09h35 HE | Lixte Biotechnology Holdings, Inc.
Extensive preclinical data shows LB-100 increases the effectiveness of chemotherapy in animal modelsDue to the aggressive progression of small cell lung cancer, it is possible that therapeutic benefit...
Quanta Logo.png
Medolife Rx Launches National TV PSA Campaign Promoting Escozine and Activates Customer Service Center
01 juin 2021 08h00 HE | Quanta, Inc.
BURBANK, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...